GAGGVGKSAL

This GAGGVGKSAL peptide represents the KRAS G12D mutant neoantigen, utilized in immunoassays and as a reference standard. It supports in vitro T-cell activation studies and in vivo research for preclinical cancer vaccine development, focusing on specific immune response evaluation against this common oncogenic driver.